Polarized lung inflammation and Tie2/angiopoietin-mediated endothelial dysfunction during severe Orientia tsutsugamushi infection

Keyphrases

• Acute Lung Injury 33%
• Angiopoietin 100%
• Angiopoietin-2 66%
• Bacterial Replication 33%
• CD11b+ 66%
• CD144 33%
• CD206 33%
• CD31+ 33%
• CD45 33%
• CD64 66%
• CD80 33%
• Cellular Immune Response 33%
• Disease Onset 33%
• Dysregulated 33%
• Endothelial Cell Culture 33%
• Endothelial Cells 33%
• Endothelial Dysfunction 100%
• Flow Cytometric Analysis 33%
• Functional Level 33%
• Future Therapeutics 33%
• High Mortality 33%
• In Vitro Infection 33%
• In Vitro Study 33%
• Inflamed Tissue 33%
• Inflammatory Response 33%
• Injury Death 33%
• Intercellular Adhesion molecule-1 (ICAM-1) 33%
• Junction Proteins 33%
• Lung 100%
• Lung Damage 33%
• Lung Inflammation 100%
• Ly6G 66%
• M1 Type 33%
• M1-like 33%
• M2 Type 33%
• M2-like 33%
• Murine Model 33%
• Neglected Tropical Diseases 33%
• Orientia 100%
• Orientia Tsutsugamushi 66%
• Orientia Tsutsugamushi Infection 33%
• Pathogenic Role 33%
• Pathological Characteristics 33%
• Patient Support 33%
• Primary Human Endothelial Cells 33%
• Protective Behavior 33%
• Pulmonary Inflammation 33%
• Pulmonary Macrophages 33%
• Scrub Typhus 33%
• Severe Scrub Typhus 33%
• Significant Loss 33%
• Specific Biomarkers 33%
• Therapeutic Research 33%
• Tie-2 Receptor 33%
• Tissue Damage 33%
• Transcriptional Level 33%
• Vascular Activation 33%
• Vascular Dysfunction 33%
• Vascular Tissue 33%
• VE-cadherin 33%

Immunology and Microbiology

• Adoptive Immunity 50%
• Angiopoietin 100%
• Angiopoietin 2 100%
• Animal Experiment 50%
• CD31 50%
• CD80 50%
• Cell Culture 50%
• Inflammation Response 50%
• Intercellular Adhesion Molecule 1 50%
• Macrophage 50%
• Orientia 100%
• Orientia tsutsugamushi 50%
• Pulmonary Inflammation 100%
• Therapeutic Research 50%
• VE-cadherin 50%